Purpose: The aim of this study was to report the clinical and histopathological features of an eyelid metastasis in a 70-year-old male with no prior medical history. Methods: A 70-year-male presented with a painless, hard, red nodular growth in his left lower medial eyelid of 6 months duration, involving the canaliculus and punctum. He did not complain of any other ocular or systemic abnormality. The clinical differential diagnosis included lymphoma or a primary adnexal tumour. The lesion was excised under local anaesthetic cover and sent for routine histopathological analysis. Results: The histology revealed a carcinoma involving the posterior and anterior lamella of the lower lid. It was composed of papillary and follicular areas. The tumour nuclei were optically clear, overlapping, had nuclear grooves and were associated with eosinophilic colloid material. The tumour cells were strongly positive for nuclear thyroid transcription factor-1 and thyroglobulin (which also stained some of the eosinophilic colloid material). The histological and immunohistochemical features were those of metastatic papillary carcinoma of the thyroid. Unfortunately, the patient's thyroid has yet to be examined because of loss to follow-up. Conclusion: To the best of our knowledge, this is the first report of thyroid papillary carcinoma metastasizing to the eyelid as the presenting feature of the disease. A review of the literature of metastatic thyroid carcinoma to the eyelids is presented, to place the findings of this case report in context.

1.
Aurora AL, Blodi FC: Lesions of the eyelids: a clinic pathological study. Surv Ophthalmol 1970;15:94-104.
2.
Arnold AC, Bullock JD, Foos RY: Metastatic eyelid carcinoma. Ophthalmology 1985;92:114-119.
3.
Wang JK, Liao SL, Jou JR, et al: Malignant eyelid tumours in Taiwan. Eye 2003;17:216-220.
4.
Weiner JM, Henderson PN, Roche J: Metastatic eyelid carcinoma. Am J Ophthalmol 1986;101:252-254.
5.
Mansour AM, Hidayat AA: Metastatic eyelid disease. Ophthalmology 1987;94:667-670.
6.
Riley FC: Metastatic tumors of the eyelids. Am J Ophthalmol 1970;69:259-264.
7.
Bianciotto CG, Demirci HY, Shields CL, Shields JA. Simultaneous eyelid and choroidal metastasis 36 years after diagnosis of medullary thyroid carcinoma. Ophthal Plast Reconstr Surg 2008;24:62-63.
8.
Bianciotto C, Demirci H, Shields CL, Eagle RC, Shields JA: Metastatic tumours to the eyelid report of 20 cases and review of the literature. Arch Ophthalmol 2009;127:999-1005.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.